SMPD3 and Parkinson disease: The inhibition of nSMase2 has been shown to reduce the secretion of EVs [reviewed in Bienias et al. (2016)], but how nSMase2 influences PD pathogenesis in terms of protein accumulation and cell-to-cell transfer has not been studied so far.